Elan Pharmaceuticals. Inc. - , US Gerald Crans - South San Francisco CA, US Ramon Hernandez - South San Francisco CA, US Jesse Cedarbaum - South San Francisco CA, US
Assignee:
Elan Pharmaceuticals. Inc. - San Francisco CA
International Classification:
A61K 31/53 A61K 31/19 A61K 31/05
US Classification:
514242, 514557
Abstract:
The invention relates generally to novel compositions and methods comprising a scyllo-inositol compound and one or both of valproic acid compound and lamotrigine. The compositions and methods provide beneficial effects in the treatment of bipolar disorders.